Ely Benaim

Affiliations

  • Chief Medical Officer at Novocure Ltd (NVCR), 2023-01-10
  • Chief Medical Officer at Rexahn Pharmaceuticals Inc. (RNN), 2019-03-01
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NVCR $74.00 5,396 $399,304.00 28,672 2022-08-03 Filing
NVCR $71.09 563 $40,023.67 34,068 2022-08-03 Filing
NVCR $69.66 437 $30,440.98 34,631 2022-08-02 Filing
NVCR $61.25 2,135 $130,768.75 34,846 2022-05-11 Filing
NVCR $65.16 2,070 $134,877.06 36,981 2022-05-10 Filing